ZH stock results show that Zhihu beat on revenue for the first quarter of 2024. More
Articles
Why UiPath Stock Is the Undiscovered AI Gem to Pounce On
What's next after the UiPath stock crash? A recovery could be imminent as UiPath's quarterly results include some notable positive points. More
BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q1 2024
BRTX stock results show that BioRestorative Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. More
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. More
Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today?
Tonix Pharmaceuticals stock is down on Wednesday after the company announced a proposed public offering for TNXP shares. More